Regnant Pharmaceuticals Private Limited
About Regnant Pharmaceuticals Private Limited
Data last updated:
Regnant Pharmaceuticals Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U26921AS1999PTC005870. Its GSTIN is 18AACCR8986R1Z4 (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Biswajit Mohan Das (Managing Director) and Surjit Mohan Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C.K. Road Panbazar Dist – Kamrup P.S. – Panbazar, Guwahati, Assam, India – 781001.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.58 Cr. For the same year it recorded a net profit of ₹95,912 (net margin 0.2%) and EBITDA of ₹2.19 Lakh (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹11.73 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Regnant Pharmaceuticals Private Limited's registered office is in Guwahati, Assam. Its e-mail address is in the company report.
- Email
- Registered AddressC.K. Road Panbazar Dist – Kamrup P.S. – Panbazar, Guwahati, Assam, India – 781001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Regnant Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Regnant Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Regnant Pharmaceuticals Private Limited, buy the company report.
Financials of Regnant Pharmaceuticals Private Limited
FY 2025 filings availableRegnant Pharmaceuticals Private Limited reported revenue of ₹4.58 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95,912 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Regnant Pharmaceuticals Private Limited, buy the company report.
Board of directors of Regnant Pharmaceuticals Private Limited
Regnant Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biswajit Mohan Das | Managing Director | 14 Sep 1999 | 27 Years 1 Months | Current |
| Surjit Mohan Das | Director | 14 Sep 1999 | 27 Years 1 Months | Current |
Peer comparison
Regnant Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aushadi Health Care Private Limited | ₹4.58 Cr (FY 2025) | 40.0% | Hyderabad, Telangana, India | |||
| Regnant Pharmaceuticals Private Limitedthis company | ₹4.58 Cr (FY 2023) | ₹95,912 | 0.2% | Guwahati, Assam, India | ||
| Makronix Life Sciences Private Limited | ₹4.57 Cr (FY 2024) | 101.0% | Vapi, Gujarat, India | |||
| Sparsh Medix Private Limited | ₹4.56 Cr (FY 2025) | 41.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Regnant Pharmaceuticals Private Limited, buy the company report.
Auditor
Regnant Pharmaceuticals Private Limited is audited by B K BHATTACHARJEE & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K BHATTACHARJEE & CO | FY 2017 | 327083E |
Shareholding
The shareholding of Regnant Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Regnant Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jan 2005 | 90266093 | Dena Bank | ₹11.73 Lakh | Open |
To see the full charge records of Regnant Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Regnant Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Regnant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Regnant Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AACCR8986R1Z4 | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Regnant Pharmaceuticals Private Limited, buy the company report.
Recent activity
Regnant Pharmaceuticals Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Biswajit Mohan Das was appointed as Managing Director on 14 Sep 1999.
Frequently asked questions
Regnant Pharmaceuticals is an active private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 1999 (27+ years old) and is registered under CIN U26921AS1999PTC005870.
Regnant Pharmaceuticals has 2 current directors:
- Biswajit Mohan Das - Managing Director
- Surjit Mohan Das - Director
The latest financial statements of Regnant Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Regnant Pharmaceuticals is 18AACCR8986R1Z4, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Regnant Pharmaceuticals is U26921AS1999PTC005870. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Regnant Pharmaceuticals was incorporated on 14 September 1999, making it 27+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Regnant Pharmaceuticals by revenue are Aushadi Health Care Private Limited, Makronix Life Sciences Private Limited, Sparsh Medix Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Biswajit Mohan Das was appointed as Managing Director on 14 Sep 1999. Surjit Mohan Das was appointed as Director on 14 Sep 1999.
The registered office of Regnant Pharmaceuticals is at C.K. Road Panbazar Dist – Kamrup P.S. – Panbazar, Guwahati, Assam, India – 781001.
Regnant Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Regnant Pharmaceuticals has open charges of ₹11.73 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
